US9757552 — Applicator for inserting an implant
Method of Use · Assigned to Merck Sharp and Dohme BV · Expires 2030-07-28 · 4y remaining
What this patent protects
This patent protects an applicator for inserting a rod-like implant containing an active substance under the skin of a human or animal.
USPTO Abstract
The invention pertains to an applicator ( 1 ) for inserting an implant, in particular a rod-like implant ( 2 ) containing an active substance, under the skin of a human or animal, comprising a housing ( 3 ), a cannula ( 6 ), a cannula holder ( 9 ), an implant ( 2 ) accommodated inside the cannula ( 6 ) and/or the cannula holder ( 9 ), a protective cover ( 7 ) for the cannula ( 6 ), and a mechanism ( 22, 23, 7 ) which, at least after the cover ( 7 ) has been removed from the cannula ( 6 ), secures the implant ( 2 ) inside the cannula ( 6 ) and/or cannula holder ( 9 ). The mechanism ( 22, 23, 7 ) disengages the implant ( 2 ) during insertion of the cannula ( 6 ) or after the cannula ( 6 ) has been inserted. Substantially no lateral force will be exerted during the expelling of the implant from the cannula.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1 |
Treatment of a specific disease/condition (broad) | Nexplanon |
U-1 |
Treatment of a specific disease/condition (broad) | Nexplanon |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.